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ABSTRACT
Bacteriophage T4 DNA polymerase was inhibited by
butylphenyl nucleotides, aphidicolin and pyrophos-
phate analogs, but with lower sensitivities than other
members of the B family DNA polymerases. The
nucleotides N2-(p-n-butylphenyl)dGTP (BuPdGTP) and
2-(p-n-butylanilino)dATP (BuAdATP) inhibited T4 DNA
polymerase with competitive Ki values of 0.82 and
0.54 ,tM with respect to dGTP and dATP, respectively.
The same compounds were more potent inhibitors in
truncated assays lacking the competitor dNTP,
displaying apparent Ki values of 0.001 and 0.0016 /tM,
respectively. BuPdGTP was a substrate for T4 DNA
polymerase, and the resulting 3'-BuPdG-
primer:template was bound strongly by the enzyme.
Each of the non-substrate derivatives, BuPdGDP and
BuPdGMPCH2PP, inhibited T4 DNA polymerase with
similar potencies in both the truncated and variable
competitor assays. These results indicate that
BuPdGTP inhibits T4 DNA polymerase by distinct
mechanisms depending upon the assay conditions.
Reversible competitive inhibition predominates in the
presence of dGTP, and incorporation in the absence
of dGTP leads to potent inhibition by the modified
primer:template. The implications of these findings for
the use of these inhibitors in the study of B family DNA
polymerases is discussed.
INTRODUCTION
The DNA polymerase encoded by bacteriophage T4 (T4 pol) is
a useful model for study of the structure and function of B family
DNA polymerases. The enzyme contains 898 amino acids, ' and
possesses both DNA polymerase and 3'-5' exonuclease
activities.2 Isolation and sequence determinations of the wild
type enzyme and numerous selected and engineered mutants have
been described.'.3-5 T4 pol is a member of the B family of
DNA polymerases, a family that includes eukaryotic enzymes
such as animal cell DNA polymerases ce, 6 and e and the
corresponding enzymes from yeast. and the DNA polymerases
from herpesviruses and other animal viruses and bacterio-
phages. 1.6.7 Because of its high amino acid sequence homology
with the B family enzymes and the availability of informative
mutants, the T4 enzyme represents a good model to study the
structure and mechanism of the polymerase and exonuclease sites
of these DNA polymerases. With respect to inhibitor profiles
which are useful for classifying DNA polymerases, the T4 pol
has been reported to be sensitive to inhibition by aphidicolin and
the nucleotide analogs, N2-(p-n-butylphenyl)-2'-deoxyguanosine
5 -triphosphate (BuPdGTP) and 2-(p-n-butylanilino)-2'-deoxy-
adenosine 5'-triphosphate (BuAdATP), properties characteristic
of B family DNA polymerases, but relatively insensitive to phos-
phonoacetic acid (PAA).8
We have studied in detail a unique series of synthetic
nucleobases and nucleotides that are potent competitive inhibitors
of certain replicative DNA polymerases. The purine dNTP analog
BuPdGTP and its adenine counterpart BuAdATP inhibit animal
cell DNA polymerase ce (pol CY)9"10 and the corresponding DNA
polymerase I from yeast"' with nanomolar potency. Other
polymerases in the B family are inhibited by BuPdGTP and
BuAdATP but with lower potencies. Animal cell DNA
polymerases 5 and c are weakly inhibited (K, ca. 100 ItM),12'13
but HSV1, 029 and T4 DNA polymerases were reported to be
inhibited in the I -10 ,uM range.8'9 In contrast to many
nucleotides that inhibit DNA polymerases largely as a
consequence of incorporation into the primer:template (reviewed
in ref. 13), BuPdGTP (and probably BuAdATP) do not appear
to be substrates for pol ce.14 Yet, T4 DNA polymerase which
is less sensitive to BuPdGTP did incorporate this nucleotide (ref.
14 and lide infra). Significantly, the prototype family A DNA
polymerase, E. coli DNA polymerase I (Klenow), was essentially
insensitive to inhibition by BuPdGTP but incorporated the
nucleotide with surprising efficiency.'5
The finding that wild type T4 pol could use BuPdGTP as a
substrate suggested that inhibitory mechanisms of this and related
compounds could be complex and could differ between nominally
homologous enzymes. For the purpose of comparisons with pol
cx, and to identify inhibitor probes of the active site of T4 pol,
we have begun a systematic study of several classes of inhibitors,
viz. butylphenyl compounds, aphidicolins and pyrophosphate
analogs, against wild type and several mutant T4 DNA
polymerases. We report in this paper that BuPdGTP, and
probably BuAdATP. inhibit wild type T4 DNA polymerase by
at least two distinct mechanisms depending on the assay
conditions.
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MATERIALS AND METHODS
Materials
Inhibitors. Nucleotide analogs were synthesized as described:
N2-(p-n-butylphenyl)guanine (BuPG), N2-(p-n-butylphenyl)-2'-
deoxyguanosine 5'-diphosphate (BuPdGDP) and its 5'-triphos-
phate (BuPdGTP);'6 2-(p-n-butylanilino)adenine (BuAA) and
2-(p-n-butylanilino)-2'-deoxyadenosine 5'-triphosphate
(BuAdATP);10 N2-(p-n-butylphenyl)-2'-deoxyguanosine 5'-(a,
/-methylene)triphosphate (BuPdGMPCH2PP) (Yanachkov and
Wright, manuscript in press in Nucleosides and Nucleotides).
Aphidicolin was a gift from the Natural Products Chemistry
Branch, National Cancer Institute, and aphidicolin derivatives
were synthesized as described.'7 Phosphonoacetic acid (PAA)
was obtained from Sigma and phosphonoformic acid (PFA) from
Fluka; tetrasodium carbonyldiphosphonate (COMDP) was
synthesized from tetraethyl methanediphosphonate as
described. 18
Enzyme. Wild type bacteriophage T4 DNA polymerase was
isolated and purified as described,'9 and was stored in aliquots
of 4.2 mg protein/mL (23000 units/mL).
Oligonucleotides. The 1 7mer and 29mer oligodeoxyribo-
nucleotides (see text for sequences) were obtained from Operon,
and the 3'-BuPdG- 18mer was synthesized as described. '5
Conditions for 5'-32P-labelling of primers, annealing of
primer:templates, and conditions for denaturing polyacrylamide-
urea gel electrophoretic (PAGE) analysis and x-radiography have
been described.'4
Enzyme assays
Assays of DNA polymerase activity were typically done in 25
,tL volumes containing 30 mM Tris-HCI (pH 7.5) and 20%
glycerol, 400 ,ig/mL activated calf thymus DNA,20 25 ,tM each
of dCTP, dATP and dGTP, 10 /tM [3H]dTTP (1250
cpm/pmol), 4 mM DTT, 10 mM Mg(OAc)2, and 100 ng of
enzyme. Reaction mixtures were incubated at 30°C for 10
minutes and stopped by the addition of 0.5 mL of ice cold 10%
trichloroacetic acid/0. 1 M sodium pyrophosphate. Acid-insoluble
product was collected on GF/A filters which were washed three
times with 0.1 M HCl/0. 1 M sodium pyrophosphate and counted
in 1 mL of Optifluor. Truncated assays lacking one dNTP were
otherwise identical to the above assays. Assays of COMDP
employed 30 mM HEPES, pH 7.5, in place of Tris buffer.
Assays with oligo dG:poly dC as primer:template were done
in 25 yL volumes containing 20 mM potassium phosphate (pH
7.5) and 20% glycerol, 0.26 mM oligo dG:poly dC (base ratio
1:10), 10 ,IM [3H]dGTP (250 cpm/pmol), 250 ,ug/mL BSA, 4
mM DTT, 0.1 mM EDTA, 10 mM MgCl2, and 100 ng of
enzyme. Incubations were done at 30°C for 10 min, and stopped
and processed as described above.
Inhibitor assays. Compounds were tested in duplicate by the
addition of twofold or threefold serial dilutions of inhibitors
dissolved in buffer (nucleotides, pyrophosphate analogs) or
Me2SO (bases, nucleosides, aphidicolins) to enzyme assay
reactions as appropriate. Control reactions for the latter inhibitors
contained the same concentration of Me2SO. For determinations
of apparent Ki values in a truncated assay or IC50 values in a
full assay, 4-6 concentrations of inhibitor were used, and the
results of at least two independent experiments were plotted as
% inhibition vs. log inhibitor concentration. Standard deviations
of the values reported in Table 1 were typically within ± 20%.
For assays involving variable concentrations of a competitor
dNTP, results were plotted (SigmaPlot) as I/pmol dTMP
incorporated vs. 1/substrate concentration at 3-4 concentrations
of dNTP (Lineweaver-Burk plots, Figure 1). Regression lines
were obtained using the program Enzyme Kinetics (D.G.Gilbert,
Indiana University) which weighted the data points. Ki values
are the average of Ki = I/[Km'/Km) - 1], where Kmi is the
apparent Km of the competitor dNTP in the presence of the
inhibitor at concentration I. Reported values are the average of
two experiments.
Primer extension reactions. These were done in 10 yL reaction
volumes in 30 mM Tris-HCI, pH 7.5, containing 5% glycerol,
4 mM DTT, 10 mM Mg(OAc)2, 1.2 /tM of 5' [32p]-
primer:template and 1 yg of T4 DNA polymerase. Reactions
were incubated for 5 min at 30°C, and terminated and processed
for PAGE analysis as described.'4
RESULTS
Inhibitor screening of wild type T4 DNA polymerase
The T4 DNA polymerase was assayed using activated DNA and
a mixture of three dNTPs, including [3H]dTTP, but lacking the
dNTP expected to be competitive with the inhibitor. (In assays
of pyrophosphate analogs all dNTPS were used.) This 'truncated'
assay without one dNTP represents a useful technique for
detecting direct competitive inhibitors of DNA polymerases,
because inhibition is amplified in the absence of the competitive
substrate. We have shown that the apparent K. values for
reversible, competitive inhibitors derived from the truncated assay
are identical to those obtained from classical variable substrate
analyses. 32' Most DNA polymerases will support synthesis in
the absence of one substrate at a level sufficient to serve as
'control' incorporation. It is essential, however, that a balance
of high specific activity of labelled dNTP and short assay times,
where incorporation of label remains linear with time, be
established for such assays to be useful.'3 Incorporation of
[3H]dTTP by T4 DNA polymerase under the truncated
conditions used in this work was linear for up to 30 minutes,
and all such inhibitor assays were done for 10 minutes. Results
of the testing of base, nucleotide, aphidicolin and pyrophosphate
analogs against wild type T4 polymerase are summarized in Table
1. The potent inhibition of the T4 enzyme by BuPdGTP and
BuAdATP, i.e. apparent K, values of about 1 nM, was similar
to that reported for DNA polymerase aC.9'10 However, the
apparent Ki value of 1 nM in the 10 minute assay (Table 1) fell
to 60 pM in a 30 minute assay. Considering that the T4 enzyme,
but not pol ae, was shown to incorporate BuPdGTP, 14 we
considered the possibility that incorporation of the modified
nucleotides resulted in a product that was strongly inhibitory to
the enzyme (see below). The corresponding nucleobases, BuPG
and BuAA, although much weaker inhibitors than the nucleotides,
had potencies similar to those reported for the bases against pol
a, 10.22,23 and inhibition in each case was reversed specifically
by the competitor nucleotide as expected (results not shown).
Aphidicolin showed significant inhibition of the enzyme, with
an apparent Ki of 10 /tM in the absence of dCTP, although this
is at least tenfold weaker that its potency against HSV 1 pol24 and
animal cell pols a, 6 and E. 12,25 Two analogs of aphidicolin were
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Figure 1. Kinetics of inhibition of T4 DNA polymerase by butylphenyl nucleotides. Reactions were done as described in Materials and Methods with activated
DNA and with dGTP or dATP as variable substrate as indicated. Results are displayed as Lineweaver-Burk plots, from which competitive K- values were obtained(see Materials and Methods). A, competition between BuPdGTP and dGTP. B, competition between BuAdATP and dATP. C, competition between BuPdGDP and
dGTP. D, competition between BuPdGMPCH2PP and dGTP. The Km values for dGTP were 3.11 M (panel A), 2.92 /tM (panel C) and 2.65 AM (panel D); theKm for dATP was 3.78 ,uM (panel B).
weaker inhibitors (Table 1), consistent with their relative activities
reported for pol (x inhibition.17
The pyrophosphate analogs phosphonoacetate (PAA) and
phosphonoformate (PFA) were weak inhibitors of T4 pol under
full assay conditions, with IC50 values of 120 and 540,tM,
respectively (Table 1). These values are much higher than those
reported for PAA and PFA inhibition of pol ce (IC50 = 15 and
21 /tM, respectively) and several herpesvirus DNA polymerases
(IC50s ca. 1 ,tM).26 Carbonyldiphosphonate (COMDP), an
inhibitor of DNA polymerases ce and e, but with tenfold selectivity
for the latter enzyme,'8 inhibited T4 pol weakly, with IC50 =
690 itM (Table 1). The weak response of the T4 enzyme is
consistent with the reported lack of effect of COMDP at 100 JtM
on the herpesvirus DNA polymerases.26 In general, although T4
DNA polymerase is less sensitive to aphidicolin and
pyrophosphate analogs, its inhibitor profile (Table 1) is similar
to that of the other B family DNA polymerases.
Kinetics of competitive inhibitors of T4 pol
To determine the mechanisms of several inhibitors of T4 pol,
we performed classical experiments using variable concentrations
of competitive dNTP, and representative results are displayed
Table 1. Inhibitors of T4 DNA polymerase
Cpd Condition' apparent Ki (jiM)
BuPdGTP -dGTP (0.001)2
BuPdGDP ' 1.9
BuPdGMPCH2PP " 2.5
BuPG 35.5
BuAdATP -dATP (0.0016)2
BuAA " 185
Aphidicolin -dCTP 10.0
16-Ketoaphidicolin " 72
3-Epiaphidicolin " 100
PFA fuill assay 120
PAA " 540
COMDP " 6903
'Assays were done as described for 10 minutes with activated DNA and four
dNTPs, includine [3H]dTTP (full assay), or with the truncated assay lacking the
indicated dNTP. These values depended upon assay time (see text). 3Assay done
with HEPES in place of Tris buffer.
in Figure 1 in the form of Lineweaver -Burk plots. The plots
revealed that inhibition by BuPdGTP (Figure lA), BuAdATP
(Figure 1B) and aphidicolin (plot not shown) was competitive
C.
0.15
a.,
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Figure 2. PAGE analysis of incorporation of BuPdGTP by T4 DNA polymerase.
Assays described in Materials and Methods utilized a 5'-32P-labelled
17mer:29mer duplex (lanes A-E), or a 5'-32P-labelled 3'-BuPdG-l8mer:29mer
duplex (lanes F -I) as primer:templates with the indicated additions (see text for
sequences). The products were separated on a 12% polyacrylamide gel by
electrophoresis at 1500 volts for 4 h, and the dried gel was exposed to X-ray
film as described (ref 14). Lane A, 25 ,uM each dGTP and dTTP. Lane B, 25
AM each dGTP, dTTP, dCTP and dATP. Lane C, 25 yM dGTP. Lane D, 10
AM BuPdGTP. Lane E, 10 AM BuPdGTP + 100 ItM dTTP. Lane F,
primer:template alone (no enzyme). Lane G, 100 ItM dTTP. Lane H, 25 tM
dTTP. Lane I, no additions (enzyme + primer:template).
with respect to dGTP, dATP and dCTP, respectively. The Ki
value derived from the results for aphidicolin was 10.7 1.8
,uM (Km for dCTP = 2.88 ttM), a value nearly identical to the
Ki obtained in the assay lacking dCTP, as expected. However,
the K1 values derived for BuPdGTP, 0.82 0.3 ,uM, and for
BuAdATP, 0.54 ±i 0. 13 AM, were much higher than those found
in the truncated assay (Table 1), suggesting different mechanisms
of enzyme inhibition under the two conditions.
The ability of BuPdGTP to interact with T4 pol specifically
as a dGTP analog was confirmed in experiments measuring
[3H]dGTP incorporation into oligo dG:poly dC. In the presence
of variable concentrations of dGTP, BuPdGTP acted as a
competitive inhibitor of the enzyme, with Ki = 80 i 12 nM,
where the Km for dGTP was 8 1.2 ttM (data not shown).
Furthermore, in separate experiments with oligo dG:poly dC,
the inhibitory effect of 125 nM BuPdGTP was not reversed in
the presence of 800 kAM of dATP, dCTP or dTTP.
Effect of non-substrate analogs of BuPdGTP
The possibility that inhibitor incorporation could explain the
difference in apparent Kis of butylphenyl nucleotides in
truncated and variable substrate assays was first tested with non-
substrate analogs of BuPdGTP. One such compound, the
5'-diphosphate BuPdGDP, was found previously to be nearly
equipotent with BuPdGTP as an inhibitor of pol c.9 BuPdGDP
displayed an apparent Ki of 1.9 AM against T4 pol in the
truncated assay lacking dGTP (Table 1), a value somewhat lower
than the Ki of 5.5 1.2 ,uM derived from assays at variable
dGTP concentrations (Figure IC). The results of the latter assay
clearly showed that BuPdGDP was competitive with dGTP as
an inhibitor of T4 pol.
Figure 3. Exonucleolytic degradation of 3'-BuPdG-18mer by T4 DNA polymerase.
Assays were done and analyzed by PAGE as described in Materials and Methods.
Incubations with T4 pol were done in the absence of dNTPs, but in the presence
of single stranded 5'-32P-labelled 3'-BuPdG-18mer (lanes E-I) or double
stranded, labelled 3'-BuPdG-18mer:29mer (lanes K-O). Lane A,
3'-BuPdG-18mer alone. Lane B, 17mer:29mer + enzyme (control). Lane C,
17mer:29mer + enzyme + 25 AM dGTP. Lanes D and J, empty. Lanes E-I,
incubations of 3'-BuPdG-18mer + enzyme for 5, 10, 20, 40 and 80 min,
respectively. Lanes K-O, incubations of 3'-BuPdG-18mer:29mer + enzyme for
5, 10, 20, 40 and 80 min, respectively.
A derivative of BuPdGTP that would be a true triphosphate
analog, but one that was expected to be non-incorporable by DNA
polymerases, was sought. We, therefore, synthesized the a, 3-
methylene derivative BuPdGMPCH2PP (manuscript in press)
and tested its effects on the T4 DNA polymerase.
BuPdGMPCH2PP inhibited T4 pol with a Ki of 2.5 ItM in the
assay lacking dGTP (Table 1). In the variable substrate assay,
the Lineweaver-Burk plot indicated that this phosphonate was
competitive with dGTP, with K1 = 2.3 0.5 ,tM (Figure ID).
These results suggested that BuPdGMPCH2PP was a non-
substrate, competitive inhibitor of the enzyme in both truncated
and variable competitor conditions. Indeed, neither
BuPdGMPCH2PP nor BuPdGDP at 10 /tM showed detectable
incorporation in primer extension reactions with T4 pol under
conditions where BuPdGTP itself completely converted primer
to 3'-BuPdG-primer (see below).
Incorporation of BuPdGTP by T4 DNA polymerase
The greater apparent potencies of BuPdGTP and BuAdATP in
truncated assays lacking the competitive substrates (Table 1) than
in assays containing those substrates (Figure 1) suggested that
the inhibitors are incorporated into primers at dGTP and dATP-
requiring sites, respectively, in the absence of the competitive
substrate, and that the resulting 3'-modified-primer:templates
strongly bind the enzyme in an unproductive complex. Indeed,
the degree of inhibition of T4 DNA polymerase by 1.25 jzM
BuPdGTP (83 ±i 3.5 %) did not vary during the linear period (16
minutes) of an assay containing a limiting concentration of dGTP
(4 IM).
In an attempt to understand the molecular mechanism(s) of
BuPdGTP-T4 pol interactions, we utilized synthetic
primer:templates and denaturing polyacrylamide-urea gel
electrophoretic (PAGE) analysis of products to study the effects
of BuPdGTP at a single incorporation site. A 5'-32P-labelled
17mer primer, 5'-d(GTAAAACGACGGCCAGT), was annealed
I.4 so4W -4
.i .:,46 :11:0.
0
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to a 29mer template, 3'-d(CATTTTGCTGCCGGTCA-
CATGCCGATCCC), and used to compare the ability of T4 pol
to incorporate dGTP or BuPdGTP to produce a normal 18mer
product or the 3 '-BuPdG- 18mer [5 '-d(GTAAAACGACGGCC-
AGTBUPG)], respectively. We also compared the latter product
with 5'-32P-labelled 3'-BuPdG-18mer, synthesized chemically as
described,'5 and asked if the 3'-BuPdG-primer:template was a
terminator of DNA synthesis. Preliminary experiments
established that 1 ug of T4 pol per assay tube (ca. 1 itM enzyme)
gave full conversion of 17mer to 29mer in the presence of 25
yM dNTPs without substantial primer degradation due to 3' to
5' exonuclease activity.
The results of the primer extension assays are summarized in
Figure 2. Both dGTP (lane C) and BuPdGTP (lane D) gave
products migrating as 18mers with weak bands at lengths of
14-16 resulting from 3 '-5' exonuclease degradation. However,
when the next substrate dTTP was present in the reaction,
extension to the l9mer only occurred when dGTP was the
substrate (lane A); no extension of the putative BuPdG-18mer
was detected in the presence of 100 ,uM dTTP (lane E).
Comparison of this result with that from direct incubation of
enzyme with synthetic 3'-BuPdG- 18mer:29mer revealed that the
modified primer was also not extended with dTTP (lanes G and
H).
The results in lane I of Figure 2 suggested that 3'-BuPdG-
modified primers were resistant to exonucleolytic cleavage by
the T4 enzyme. A more complete study (Figure 3) indicated that
this resistance is relative. Incubation of double stranded
3'-BuPdG-18mer:29mer with enzyme alone resulted in
degradation of primer, but with a half life greater than 80 min
(lanes K-0). In contrast, double stranded 17mer:29mer
degraded to near completion in 10 min (lane B). Single stranded
3'-BuPdG-18mer was degraded rapidly by the enzyme (lanes
E-J), however, with a half life of less than 10 min. Thus, in
stark contrast to the complete resistance of single stranded
3'-BuPdG-primers to exonucleolytic degradation by E.coli pol
1,15 the T4 polymerase is able to remove 3'-BuPdGMP, but at
a considerably lower rate than removal of dGMP.
Does the 3'-BuPdG-18mer inhibit T4 DNA polymerase?
The question of whether 3 '-BuPdG-primer:templates had unusual
affinity for T4 DNA polymerase was addressed in a
'sequestration' experiment in which the effect of primer:template
on incorporation of [3H]dGTP into oligo dG:poly dC by T4 pol
was monitored. The 3 '-BuPdG- 18mer:29mer duplex, which
could not itself incorporate label, inhibited this reaction (at 10
AcM dGTP) with IC50 = 73 nM (as 3'-OH groups),
approximately the value of the Ki derived for inhibition of the
oligo dG:poly dC reaction by BuPdGTP. (There is no strict single
or double-stranded 'control' oligomer for comparison with this
result, because these can be either degraded (single stranded,
double stranded) or extended (double stranded) when added to
the assay.) Neither assay time, up to 20 min, nor preincubation
of 3'-BuPdG-18mer:29mer with enzyme, for 30 min at 0°C,
affected inhibitory activity in this assay (data not shown). Thus,
the interaction between polymerase and 3'-BuPdG-primer:
template is reversible under the assay conditions employed.
In a similar experiment with the concentration of
3'-BuPdG-18mer:29mer fixed at 500 nM, addition of 100 ,uM
dTTP (i.e. the next substrate) did not increase the degree of
inhibition of T4 pol, suggesting that binding of the modified
primer:template did not require the dNTP substrate. This
contrasts with the mechanism of typical chain terminating
substrates in which terminated primer:templates complex strongly
with DNA polymerases only in the presence of the next dNTP
substrate.2>-29 The possible lack of affinity of 3'-BuPdG-
primer:templates for the next dNTP when bound to the T4
polymerase molecule may explain the inability of the modified
primer to be extended by that substrate (Figure 2).
DISCUSSION
The response of T4 DNA polymerase to selected inhibitors was
qualitatively similar to that of other B family enzymes, but there
were some significant differences. For example, the T4 DNA
polymerase was less sensitive than DNA polymerase a to
aphidicolin and pyrophosphate analogs and to the butylphenyl
nucleotides, BuPdGTP and BuAdATP; however, unlike pol ca,
the T4 enzyme incorporated the latter inhibitors. In addition, the
butylphenyl nucleotide-terminated primer:template was a potentinhibitor of T4 DNA polymerase.
Evidence for this unique mechanism of T4 DNA polymerase
inhibition by butylphenyl nucleotides was derived from several
experiments. First, BuPdGDP and BuPdGMPCH2PP, non-
incorporable analogs of BuPdGTP, inhibited the T4 enzyme with
similar potencies in the truncated (Table 1) and variable
competitor assays (Figures IC and ID). Second, the enzyme
utilized BuPdGTP to extend a primer:template at a site requiring
dGTP incorporation but could not extend the modified primer(Figure 3). Third, a synthetic 3'-BuPdG-primer:template inhibited
T4 pol in the reaction of [3H]dGTP with oligo dG:poly dC with
a potency close to the K, of BuPdGTP in the same reaction. The
apparent 'nanomolar' potency of butylphenyl nucleotides in
truncated assays of T4 pol with activated DNA is likely a direct
result of their incorporation, in contrast to the 'micromolar'
potency of the same compounds in full assays. DNA polymerase
ac, which has been shown not to incorporate BuPdGTP,14 thus
remains a uniquely nanomolar-sensitive B family DNA
polymerase to reversible, competitive inhibition by these
compounds.
Incorporation of butylphenyl nucleotides per se would not
necessarily lead to inhibition of T4 DNA polymerase activity.
Indeed, E. coli DNA polymerase I (Klenow), an enzyme that is
very resistant to BuPdGTP in full assay conditions, incorporated
the nucleotide readily.'5 The 3'-BuPdG-primers were resistant
both to extension and to exonucleolytic degradation by pol I.
BuPdGTP actually increased pol I-catalyzed incorporation of
[3H]dTTP in a truncated assay lacking dGTP, likely as a result
of protection of modified primers from exonuclease digestion.'5
The latter result, in fact, implies that pol I does not appreciably
bind the BuPdG-primer:templates. Indeed, the synthetic
3'-BuPdG-18mer:29mer did not inhibit pol I (Klenow) in
sequestration experiments like those described above for T4 DNA
polymerase (data not shown). Although T4 pol also incorporated
BuPdGTP and could not extend the modified primers (see above),
it is significantly different from pol I in its high affinity for the
3'-BuPdG-primer:templates and in its ability to remove the
3'-BuPdGMP residue.
Inhibition resulting from incorporation of BuPdGTP (and
BuAdATP) by T4 DNA polymerase or other DNA polymerases
confounds the measurement of the direct affinity of the inhibitors
for the enzymes. This is especially important for comparison of
sensitivity of different enzymes, and for interpretation of the
effects of the nucleotides on mutant T4 pols (work in progress).
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The similar potency of the a, f-methylene triphosphate derivative
BuPdGMPCH2PP in truncated and variable substrate assays is
fully consistent with its inability to be a substrate for T4 DNA
polymerase. Furthermore, its potency is only about threefold
lower than that of BuPdGTP in the variable substrate assay,
indicating a small effect of the methylene substitution on binding
of the nucleotide. The finding that BuPdGMPCH2PP inhibited
calf thymus DNA polymerase a in the truncated assay with K1
= 9.5 nM, only fivefold lower than that of BuPdGTP (manuscript
in press), indicates that this analog will be of significant use in
studying affinities of butylphenyl nucleotides for B family DNA
polymerases in the absence of incorporation.
Despite protein sequence similarities, B family DNA
polymerases differ quantitatively and qualitatively in their
response to the butylphenyl nucleotides. In addition to the T4
DNA polymerase described in this work, several of the
polymerases with intermediate sensitivity to BuPdGTP and
BuAdATP also incorporate the inhibitors, i.e. HSV 1 pol
(K.-W. Knopf, personal communication) and o29 pol (M.Salas,
personal communication). Study of BuPdGTP/BuAdATP
inhibitory potencies, incorporation kinetics and interaction of
BuPdG/BuAdA-modified primer:templates with DNA poly-
merases, especially with mutant enzymes, may prove of value
in analysis of the function of active site residues in B family DNA
polymerases.
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